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Abstract
Comparing self-reports to administrative records, we find that survey respon-
dents are significantly more likely to under-report mental illnesses compared to
other health conditions. This behavior is consistent with the existence of stigma of
mental illnesses. We show that stigma can play a role in determining health-seeking
behavior.
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1 Introduction
The fear of being stigmatized or socially sanctioned and disgraced governs many aspects
of human behavior. In many cases, the fear of stigma does not result in actual behavior
change but rather leads individuals to simply hide certain behaviors or actions (for ex-
ample, smoking in secrecy). This is in line with the definition of stigma in the seminal
work on the topic by Goffman (1963).
We show the existence and consequences of stigma in an important area of public health
concern: mental health.1 We compare survey self-reports on diagnoses and mental health
drug use to administrative data on prescription drug use in a sample of more than 250,000
individuals. While there could be various drivers for the differences between survey
self-reports and administrative data, our leading explanation is that if mental illnesses
were not stigmatized, the difference between self-reported survey responses and objective
administrative records should be statistically similar to other diseases.
While a large literature in psychology and psychiatry has examined the existence of
stigma in mental health (see examples in Corrigan (2000)) the approach of using relative
misreporting of mental health in a heterogenous sample of about a quarter of a million
individuals, is novel.2 Our work also complements a recent set of papers that focus on
stigma in the case of Human Immunodeficiency Virus (HIV) (Thornton 2008, Derksen
et al. 2014, Hoffmann et al. 2014, Ngatia 2011) and papers that match self-reported health
measures to administrative health records (see Harlow & Linet (1989), Baker et al. (2004),
and Johnston et al. (2009)). These papers however, do not focus on mental health report-
ing. Hence, while it may be intuitive and taken for granted that there is stigma in mental
health, empirically documenting its existence using a large administrative database is
novel.
2 Methods and data
For the empirical analysis, we use a unique data set from Australia. The 45 and Up
Study is a survey of more than 250,000 individuals 45 years of age or older residing in
New South Wales (NSW), the most populous state of Australia. The survey, with the
1In the working paper version (Bharadwaj et al. 2015), we construct a simple model of stigma and
choices in the face of stigma.
2Some recent work examines misreporting in mental health related visits to general practitioners
(GPs), such as Palin et al. (2011). However, the sample size used in Palin et al. (2011) is quite small
(145 patients), and misreporting of visits for reasons other than mental health is not examined. Rhodes
et al. (2002) document misreporting of mental health in a larger sample of individuals, however, they too,
do not examine misreporting in other health conditions. Using administrative data and cross sectional
data from Taiwan, Wu et al. (2014) report match rates between self reports and medical claims records,
but mental health and depression is not a focus of their work.
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consent of all the participants, is linked to the individuals’ administrative health records,
including prescription drugs and doctor visits. We use the data covering the period of
2007-2010 (233,081 observations). Panel A of Table B.1 presents the descriptive statistics
of demographic and socioeconomic variables in our analysis sample.
We investigate the extent of under-reporting of mental illness by matching self-reported
mental health information in the 45 and Up Study to the administrative records of filled
prescriptions for mental health disorders. The drugs for depression and other conditions
are identified using the Anatomical Therapeutic Chemical (ATC) codes, listed in Ap-
pendix A.1. We use two types of self-reported measures of mental health from the 45 and
Up study - self reports of diagnosis and self reports of prescription drug use.
First, individuals are asked whether a doctor has ever told them that they have a list
of health conditions, including mental disorders (see Appendix Figure B.1). In the ad-
ministrative records, we can observe whether an individual has filled any prescriptions
for depression drugs from September 2005 until the survey date. To evaluate the extent
of under-reporting of mental illness, we calculate the proportion of individuals observed
filling prescriptions for depression drugs who do not report that they have been diag-
nosed with depression or anxiety.3 We also compute the under-reporting rates of other
health conditions: cardiovascular diseases (hypertension, heart disease, and stroke) and
diabetes.
Second, in the 45 and Up Study, individuals are asked about their use of selected pre-
scription drugs in the past four weeks (see Appendix Figure B.2). We calculate the
under-reporting rate of depression drugs as a proportion of the individuals observed fill-
ing a prescription for any of the three depression drugs4 who do not report using any of
these drugs in the survey. We also estimate the under-reporting rates of drugs used for
treatment of the following other conditions: cardiovascular and blood diseases (hyper-
tension, congestive heart failure, high blood cholesterol, and thrombosis), diabetes, and
other diseases (heartburn, gout, and thyroid disease).
3 Results
Table 1 presents the estimated under-reporting rates of mental disorders and other condi-
tions. Panel A of Table 1 shows that 36.5% of people observed using depression drugs in
the administrative data do not report that they have been diagnosed with either depres-
sion or anxiety. The average under-reporting rate of all other diagnoses is substantially
lower at 17%. Diabetes has the lowest under-reporting rate (11%). Panel B of Table
3Anxiety disorders are often treated with depression drugs (AMH 2015).
4Zoloft (sertaline), Cipramil (citaloprim), and Efexor (venlafaxine).
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1 reports the under-reporting rates of prescription drugs. The under-reporting rate of
depression drugs is equal to 20%. The under-reporting rates of the other drugs are lower
(13%-14%). Table 2 examines under-reporting for a subset of people who use multiple
drugs. This analysis is akin to an individual fixed-effects model. For example, we take an
individual observed as taking drugs for both depression and diabetes, and examine the
relative excess under-reporting of mental illness for the same individual. Column 2 in Ta-
ble 2 shows that among people who take both drugs, mental illness diagnosis and drug use
is under-reported 45% and 22% of the time, respectively, whereas diabetes diagnosis or
drug use is under-reported only 14% of the time. Overall, the results presented in Tables
1 and 2 suggest that the stigma of mental illness can lead to substantial under-reporting
of mental disorders in the survey data.
Table 1: The under-reporting rates of mental illness (MI) and other conditions
Under-reporting rate Difference from MI
Estimate S.E. Estimate S.E. n
A. Self-reported diagnoses
Mental illness 0.365 (0.003) - - 31,199
Other conditions: 0.169 (0.001) −0.196∗∗∗ (0.003) 94,188
Cardiovascular diseases 0.178 (0.001) −0.187∗∗∗ (0.003) 80,344
Diabetes 0.113 (0.003) −0.252∗∗∗ (0.004) 13,844
B. Self-reported prescription drug use
Mental illness 0.196 (0.005) - - 5,810
Other conditions: 0.136 (0.001) −0.059∗∗∗ (0.005) 108,045
Cardiovascular diseases 0.139 (0.001) −0.057∗∗∗ (0.005) 77,711
Diabetes 0.129 (0.005) −0.067∗∗∗ (0.007) 5,026
Other diseasesd 0.130 (0.002) −0.066∗∗∗ (0.006) 25,308
Notes : Standard errors (clustered at the individual level) in parentheses. ∗∗∗ indicates
that the under-reporting rate of the condition is different from the under-reporting rate
of mental illness at the 1% significance level.
Next, we explore alternative explanations besides stigma for our results. First, we ad-
dress the possibility that our results are driven by doctor, rather than patient, behavior.
To explore this possibility , we restrict the sample to the individuals who were treated
for both depression and cardiovascular disease by the same doctor, and the doctors who
treated two or more such patients (14,838 patients, 4,192 doctors). We then regress the
difference in under-reporting of depression and cardiovascular disease diagnosis on indi-
vidual demographic and socioeconomic characteristics and doctor fixed-effects. Doctor
fixed-effects are jointly insignificant in this regression, suggesting that doctor communi-
cation style is not driving differential under-reporting of mental illness relative to other
conditions (F-statistic = 1.010, p-value = 0.345). Thus, we believe that doctor behavior
is not a leading candidate in explaining our results.
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Table 2: Within-individual differences in the under-reporting rates of mental illnesses (MI)
and other conditions
MI & CVD MI & Diabetes MI, CVD, & Diabetes
(1) (2) (3)
A. Self-reported diagnoses
Mental illness 0.441 0.446 0.462
(0.004) (0.008) (0.009)
Cardiovascular diseases 0.213 - 0.202
(0.003) - (0.007)
[−0.227]∗∗∗ - [−0.260]∗∗∗
Diabetes - 0.140 0.133
- (0.006) (0.006)
- [−0.307]∗∗∗ [−0.329]∗∗∗
Observations 17,521 3,523 3,098
B. Self-reported prescription drug use
Mental illness 0.221 0.224 0.250
(0.010) (0.023) (0.030)
Cardiovascular diseases 0.144 - 0.149
(0.009) - (0.025)
[−0.077]∗∗∗ - [−0.101]∗∗∗
Diabetes - 0.142 0.144
- (0.019) (0.024)
- [−0.081]∗∗∗ [−0.106]∗∗∗
Observations 1,636 344 208
Notes : The sample consists of individuals who take drugs for mental illness as well
as cardiovascular disease and/or diabetes. MI stands for mental illness, and CVD for
cardiovascular disease. Standard errors in parentheses. The differences between the
under-reporting rates of respective condition and mental illnesses in square brackets.
∗∗∗ indicates that the under-reporting rate of the condition is different from the under-
reporting rate of mental illness at the 1% significance level.
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Second, individuals may not recall that they have been diagnosed with a mental illness.
This is unlikely in our setting as we only focus on recent treatments for depression.
Moreover, if we only use the data on the prescription drug use in the past 12 months,
the under-reporting rates of depression and other conditions change only slightly (32%
and 15%, respectively). Another way of addressing this is shown in Figure B.3. Figure
B.3 shows that among individuals who have been treated for depression for short periods
of time, the under-reporting rate of mental illness diagnosis is higher than 50%. Among
those who have been treated for depression for relatively long periods of time, the under-
reporting rate of mental illnesses is close to 20%. Importantly, individuals are more likely
to under-report mental illness compared to other conditions, irrespective of treatment
intensity.5
Finally, we examine whether characteristics associated with mental illness under-reporting
also predict health-seeking behavior. Appendix Table B.2 shows that males, individu-
als without university degree, and those from Asian, African, or Middle Eastern eth-
nic backgrounds are significantly more likely to under-report mental illness. We first
identify individuals who are deemed to be in “need” of mental health treatment accord-
ing to the Kessler Psychological Distress Scale (K10), as explained in Appendix A.2
(n = 1, 620). We then use the results from Appendix Table B.2 to predict the proba-
bilities of under-reporting mental illness diagnosis and mental health drug use for these
individuals. In the final step, we examine whether these predicted probabilities are cor-
related with treatment-seeking behavior in the subsequent 12 months.6 Table 3 presents
the results. Consistent with our initial hypothesis that stigma might play a role in pre-
venting health care seeking, we find that individuals with a higher predicted probability
of under-reporting are also less likely to seek mental health care (even though they are
more likely to seek care from a GP).
4 Concluding remarks
Conditional on taking prescription medication, we find that individuals are significantly
more likely to under-report mental health ailments, compared to other conditions. We
interpret the additional misreporting in mental health conditions as evidence of the stigma
of mental health. Our interpretation of misreporting as evidence of stigma is based on a
broad definition of stigma. Since we only observe individual agents’ reporting choices, we
are unable to separate misreporting directly due to social discrimination concerns from
misreporting due to the agent’s intrinsic motivations such as guilt, shame, self-image
issues, etc. In our context, therefore, stigma is an amalgam of these forces. We posit
5In the working paper version (Bharadwaj et al. 2015), we provide additional sensitivity checks.
6To perform this analysis, we need to make some sample restrictions, described in Appendix A.2.
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that these intrinsic motivations also arise indirectly from the same basic force—in the
absence of discrimination concerns, there is nothing to feel shameful/guilty about. We
do, however, attempt to separate this notion of stigma from concerns about labor market
discrimination—since a large portion of our sample is retired, we can assume that for
this subsample there is no labor market based statistical discrimination motive in their
responses. In future work, we hope to shed light on the more nuanced differences between
discrimination concerns and the related intrinsic motivations mentioned above.
Table 3: Variation in health care seeking by predicted probability of under-reporting of mental
illness and other conditions
Diagnosis Drug use
GP visits MH treat. MH treat. GP visits MH treat. MH treat.
(1) (2) (3) (4) (5) (6)
P̂ rob(URMI) 4.056
∗∗∗ −0.165∗∗∗ - 7.424∗∗∗ −0.373∗∗∗ -
(1.036) (0.063) (1.835) (0.129)
P̂ rob(UROther) - - 0.279 - - −0.258
(0.171) (0.259)
GP visits last year 0.671∗∗∗ 0.004∗∗∗ 0.003∗∗∗ 0.679∗∗∗ 0.004∗∗∗ 0.003∗∗∗
(0.020) (0.001) (0.001) (0.021) (0.001) (0.001)
Mean(dep var) 10.747 0.175 0.175 10.747 0.175 0.175
Observations 1,618 1,618 1,618 1,618 1,618 1,618
Notes: See Appendix A.2 for the details on the sample. In Columns (1) and (4), the dependent
variable is the number of GP visits in the next 12 months from the survey date and presented
figures are OLS coefficients. In Columns (2), (3), (5), and (6), the dependent variable takes the
value 1 if an individual took prescription drugs for depression/anxiety or visited a mental health
professional in the next 12 months from the survey date and the value 0 otherwise and presented
figures are probit average marginal effects. P̂ rob(URMI) is the predicted probability of under-
reporting mental illness diagnosis (in columns 1-2) or mental health drug use (in columns 4-5),
calculated using the estimates presented in Appendix Table B.2. P̂ rob(UROther) is the predicted
probability of under-reporting other illness diagnosis (in column 3) or other drug use (in column
6). Standard errors (presented in parentheses) are calculated using bootstrap method with 250
replications. ∗∗∗denotes statistical significance at the 1% level.
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